CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells.

MLA

Bommi-Reddy, Archana, et al. “CREBBP/EP300 Acetyltransferase Inhibition Disrupts FOXA1-Bound Enhancers to Inhibit the Proliferation of ER+ Breast Cancer Cells.” PloS One, vol. 17, no. 3, Mar. 2022, p. e0262378. EBSCOhost, https://doi.org/10.1371/journal.pone.0262378.

APA

Bommi-Reddy, A., Park-Chouinard, S., Mayhew, D. N., Terzo, E., Hingway, A., Steinbaugh, M. J., Wilson, J. E., Sims, R. J., 3rd, & Conery, A. R. (2022). CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells. PloS One, 17(3), e0262378. https://doi.org/10.1371/journal.pone.0262378

Chicago

Bommi-Reddy, Archana, Sungmi Park-Chouinard, David N Mayhew, Esteban Terzo, Aparna Hingway, Michael J Steinbaugh, Jonathan E Wilson, Robert J Sims 3rd, and Andrew R Conery. 2022. “CREBBP/EP300 Acetyltransferase Inhibition Disrupts FOXA1-Bound Enhancers to Inhibit the Proliferation of ER+ Breast Cancer Cells.” PloS One 17 (3): e0262378. doi:10.1371/journal.pone.0262378.